7-Bromo-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione, 97.0%, 250mg

(S)-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)acetamide, 98%, 50mg

QUINAZOLINE-8-CARBOXYLIC ACID, 95%, 1g

Bosutinib, 99%, 1g

N-(3-hydroxyazetidin-1-yl)(tert-butoxy)formamide, 95.0%, 10g

4,4'-Dibromo-2,2'-dinitro-1,1'-biphenyl, 99+%, 10g

Nalpha-(tert-Butoxycarbonyl)-L-arginine Hydrochloride Monohydrate>98.0%(T)5g

Sodium 2-methyl-2-propanethiolate, 90.0%, 1g

ROTI® SampleLyse Hard Tissue, 6 pcs 6 pcs

3,4-Difluorophenylacetic acid methyl ester, 98.0%, 1g

2,4-Dichloro-5-iodopyrimidine>98.0%(GC)1g

3-Amino-4-bromobenzotrifluoride, 95.0%, 1g

3,5-Dichloro-4-fluorobenzene sulfonamide, 1g